Resources

The industries we serve are fast moving and complex with changing regulations, technology and innovations. The physIQ team is here to help you make sense of it all. Check back often for updated resources.

Oncology Study with Janssen

Chris Economos of physIQ and Bert Hartog of Janssen discuss how they are working with HagaHospital (The Hague, Netherlands) to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. Funded by Janssen Pharmaceuticals, the study is evaluating how clinicians can leverage this technology to proactively identify and manage adverse events that may result from chemotherapy and immunotherapy, with potential to establish safety-related digital biomarkers.

FEATURED RESOURCES

Importance of analytics to make sense of variability of physiological data
Importance of analytics to make sense of variability of physiological data

In this installment of Digital Medicine Discussions, Dr. Steve Steinhubl identifies the importance of analytics to make sense of the variability of blood pressure data. 

Leveraging Continuous Biosensor Data: A Discussion of What Makes an Enterprise-Ready Platform
Leveraging Continuous Biosensor Data: A Discussion of What Makes an Enterprise-Ready Platform

In this white paper, we outline the key considerations for evaluating potential solutions aimed at leveraging remote-monitoring data to inform patient care management or care delivery.

Oncology Study with Janssen
Oncology Study with Janssen

PhysIQ partnered with Janssen to deploy accelerateIQTM to detect physiological anomalies during and after anti-cancer treatment. 

Contact us and transform the future of real-world patient insight.

At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.

Contact Us